<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pre-emptive antiviral therapy based on the early detection of <z:e sem="disease" ids="C0010823" disease_type="Disease or Syndrome" abbrv="">CMV infection</z:e> is an important strategy for the prevention of CMV disease following allogeneic BMT </plain></SENT>
<SENT sid="1" pm="."><plain>Accepted methods for early detection of <z:e sem="disease" ids="C0010823" disease_type="Disease or Syndrome" abbrv="">CMV infection</z:e> include <z:mp ids='MP_0001799'>viral</z:mp> culture of blood or bronchial lavage specimens or CMV pp65 antigenemia testing of peripheral blood specimens </plain></SENT>
<SENT sid="2" pm="."><plain>We describe a patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with worsening liver transaminases after allogeneic bone marrow transplantation who had repeated negative tests for CMV pp65 antigenemia despite positive <z:mp ids='MP_0001799'>viral</z:mp> blood cultures </plain></SENT>
<SENT sid="3" pm="."><plain>Re-examination of peripheral blood samples with a different pp65 antibody pool revealed the presence of high levels of CMV in peripheral blood leukocytes, confirming a lack of reactivity to the original antibody pool </plain></SENT>
<SENT sid="4" pm="."><plain>Following institution of antiviral therapy, a prompt reduction in the number of pp65 antigen-positive peripheral blood leukocytes paralleled a reduction in abnormal transaminases </plain></SENT>
<SENT sid="5" pm="."><plain>The practical implications of these findings are discussed </plain></SENT>
</text></document>